Correspondence

WACHTELL, LIPTON, ROSEN & KATZ

 

MARTIN LIPTON

HERBERT M. WACHTELL

BERNARD W. NUSSBAUM

LAWRENCE B. PEDOWITZ

PAUL VIZCARRONDO, JR.

PETER C. HEIN

HAROLD S. NOVIKOFF

MEYER G. KOPLOW

THEODORE N. MIRVIS

EDWARD D. HERLIHY

DANIEL A. NEFF

ERIC M. ROTH

ANDREW R. BROWNSTEIN

MICHAEL H. BYOWITZ

PAUL K. ROWE

MARC WOLINSKY

DAVID GRUENSTEIN

STEPHEN G. GELLMAN

STEVEN A. ROSENBLUM

STEPHANIE J. SELIGMAN

 

JOHN F. SAVARESE

SCOTT K. CHARLES

DAVID S. NEILL

JODI J. SCHWARTZ

ADAM O. EMMERICH

GEORGE T. CONWAY III

RALPH M. LEVENE

RICHARD G. MASON

MICHAEL J. SEGAL

DAVID M. SILK

ROBIN PANOVKA

DAVID A. KATZ

ILENE KNABLE GOTTS

DAVID M. MURPHY

JEFFREY M. WINTNER

TREVOR S. NORWITZ

BEN M. GERMANA

ANDREW J. NUSSBAUM

RACHELLE SILVERBERG

STEVEN A. COHEN

 

51 WEST 52ND STREET

NEW YORK, N.Y. 10019-6150

TELEPHONE: (212) 403 - 1000

FACSIMILE: (212) 403 - 2000

                         

 

GEORGE A. KATZ (1965-1989)

JAMES H. FOGELSON (1967-1991)

                         

 

OF COUNSEL

 

DEBORAH L. PAUL

DAVID C. KARP

RICHARD K. KIM

JOSHUA R. CAMMAKER

MARK GORDON

JOSEPH D. LARSON

LAWRENCE S. MAKOW

JEANNEMARIE O’BRIEN

WAYNE M. CARLIN

STEPHEN R. DiPRIMA

NICHOLAS G. DEMMO

IGOR KIRMAN

JONATHAN M. MOSES

T. EIKO STANGE

DAVID A. SCHWARTZ

JOHN F. LYNCH

WILLIAM SAVITT

ERIC M. ROSOF

MARTIN J.E. ARMS

GREGORY E. OSTLING

DAVID B. ANDERS

 

ADAM J. SHAPIRO

NELSON O. FITTS

JEREMY L. GOLDSTEIN

JOSHUA M. HOLMES

DAVID E. SHAPIRO

DAMIAN G. DIDDEN

ANTE VUCIC

IAN BOCZKO

MATTHEW M. GUEST

DAVID E. KAHAN

DAVID K. LAM

BENJAMIN M. ROTH

JOSHUA A. FELTMAN

ELAINE P. GOLIN

EMIL A. KLEINHAUS

KARESSA L. CAIN

RONALD C.CHEN

GORDON S. MOODIE

DONGJU SONG

BRADLEY R. WILSON

   

 

WILLIAM T. ALLEN

PETER C. CANELLOS

DAVID M. EINHORN

KENNETH B. FORREST

THEODORE GEWERTZ

MAURA R. GROSSMAN

RICHARD D. KATCHER

THEODORE A. LEVINE

DOUGLAS K. MAYER

ROBERT B. MAZUR

PHILIP MINDLIN

 

 

ROBERT M. MORGENTHAU

ERIC S. ROBINSON

PATRICIA A. ROBINSON*

LEONARD M. ROSEN

MICHAEL W. SCHWARTZ

ELLIOTT V. STEIN

WARREN R. STERN

PATRICIA A. VLAHAKIS

J. BRYAN WHITWORTH

AMY R. WOLF

   
   

* ADMITTED IN THE DISTRICT OF COLUMBIA

                          

 

COUNSEL

   
   

 

DAVID M. ADLERSTEIN

MICHELE J. ALEXANDER

AMANDA K. ALLEXON**

LOUIS J. BARASH

DIANNA CHEN

ANDREW J.H. CHEUNG

PAMELA EHRENKRANZ

KATHRYN GETTLES-ATWA

 

 

PAULA N. GORDON

NANCY B. GREENBAUM

MARK A. KOENIG

J. AUSTIN LYONS

SABASTIAN V. NILES

AMANDA N. PERSAUD

JEFFREY A. WATIKER

   
    ** ADMITTED IN THE STATE OF ILLINOIS    

June 11, 2013

VIA EDGAR

Mr. Jeffrey P. Riedler

Assistant Director

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:   

Mallinckrodt plc

Registration Statement on Form 10-12B

File No. 001-35803

Dear Mr. Riedler:

Reference is made to the Registration Statement on Form 10 (File No. 001-35803) (as amended to date, the “Registration Statement”), filed by Mallinckrodt plc (the “Company”) with the U.S. Securities and Exchange Commission (the “Commission”). We understand that the New York Stock Exchange (the “NYSE”) has certified to the Commission that the ordinary shares of the Company (the “Shares”) have been approved for listing and registration.

Covidien plc (“Covidien”) has set June 19, 2013 as the record date for the distribution of the Shares, which is scheduled to occur on June 28, 2013. Covidien and the Company would like for the Shares to commence trading on the NYSE on a “when issued” basis as soon as practicable


Jeffrey P. Riedler

U.S. Securities and Exchange Commission

June 11, 2013

Page 2 of 2

 

and potentially as early as June 17, 2013, two days prior to the record date. Accordingly, the Company hereby requests that the effective date for the Registration Statement be accelerated to 5:00 p.m., Eastern time, on June 13, 2013, or as soon as practicable thereafter, pursuant to Section 12(d) of the U.S. Securities Exchange Act of 1934, as amended, and Rule 12d1-2 thereunder.

The Company hereby acknowledges that:

 

   

should the Commission or the Staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

   

the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

   

the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If the Staff has any further questions or comments concerning this letter, or if you require any additional information, please feel free to contact Victor Goldfeld of Wachtell, Lipton, Rosen & Katz at (212) 403-1005. We request that we be notified of the effectiveness of the Registration Statement by a telephone call to Mr. Goldfeld and that such effectiveness also be confirmed in writing.

Sincerely,

/s/ Victor Goldfeld

Victor Goldfeld

 

cc:   

Jack Kapples

Vice President and Corporate Secretary

Covidien plc

 

Miriam Singer

Vice President and Corporate Secretary, Pharmaceutical Products

Covidien plc